Rethinking governance for trade and health

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Walls, Helen ^a   Smith, Richard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; DECISION MAKING; ECONOMIC ASPECT; EDITORIAL; EUROPEAN UNION; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH HAZARD; HUMAN; INVESTMENT; PATENT; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED STATES; WORLD HEALTH ORGANIZATION; COMMERCIAL PHENOMENA; CONFLICT; DRUG INDUSTRY; HEALTH; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE;

COMMERCE; DECISION MAKING; DISSENT AND DISPUTES; DRUG INDUSTRY; GLOBAL HEALTH; HUMANS; INTERNATIONAL COOPERATION; PUBLIC HEALTH;

EID: 84940121414     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h3652     Document Type: Editorial

References (24)

1. Lee K, Sridhar D, Patel M. Bridging the divide: global governance of trade and health. Lancet 2009;373:416-22.
2. Gleeson D, Friel S. Emerging threats to public health from regional trade agreements. Lancet 2013;381:1507-9.
3. Sanders L, Moulton K, Paggi M, Goodwin B. The GATT Uruguay round and the World Trade Organization: opportunities and impact for US agriculture.. www.ces.ncsu.edu/depts/agecon/trade/seven.html.
4. Friel S, Gleeson D, Thow A, et al. A new generation of trade policy: potential risks to diet-related health from the Trans Pacific Partnership agreement. Global Health 2013;9:46.
5. Bennet N. Health concerns raised over EU-US trade deal. Lancet 2014;384:843-4.
6. Thow AM, Snowdon W, Labonte R, et al. Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific Partnership Agreement. Health Policy 2015 119:88-96.
7. Monasterio E, Gleeson D. Pharmaceutical industry behaviour and the Trans Pacific Partnership Agreement. N Z Med J 2014;127:6-12.
8. Provost C, Kennard M. The obscure legal system that lets corporations sue countries. Guardian 2015 Jun. 10. www.theguardian.com/business/2015/jun/10/obscure-legal-systemletscorportations-sue-states-ttip-icsid.
9. Reynolds L, McKee M. Is the NHS really safe from international trade agreements? BMJ 2015;350:h2179.
10. Faunce T. Plain packaging in a broader regulatory framework: preventing false claims and investor-state lobbying. In: Mitchell A, Voon T, Liberman J, eds. Public health and plain packaging of cigarettes: legal issues. Edward Elgar, 2012:200-13.
11. Walls H, Baker P, Smith R. Moving towards policy coherence in health and trade. J Public Health Policy (forthcoming).
12. Gornall J. New Pacific trade deal.good for pharma, bad for public health. BMJ 2015;351:h3649.
13. Hilary J. The Transatlantic Trade and Investment Partnership and UK healthcare. BMJ 2014;349:g6552.
14. Jarman H. Attack on Australia: Tobacco industry challenges to plain packaging. J Public Health Policy 2013;34:375-87.
15. Vines T, Crow K, Faunce T. Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA. J Law Med 2012;20:280-94.
16. Davies P. Trade secrets: will an EU-US treaty enable US big business to gain a foothold? BMJ 2013;346:f3574.
17. Walls H, Smith R, Drahos P. Improving regulatory capacity to manage risks associated with trade agreements. Global Health 2015;11:14.
18. Corporate Europe Observatory. Who lobbies most on TTIP? 2014. http://corporateeurope.org/international-trade/2014/07/who-lobbies-most-ttip.
19. Thaiprayoon S, Smith R. Capacity building for global health diplomacy: Thailand's experience of trade and health. Health Policy Plan 2014 Oct. 21. [Epub ahead of print.]
20. WHO Country Office for Thailand. International trade and health programme: framework on strategic development towards policy coherence between international trade and health.. WHO, 2011.
21. Smith RD, Lee K, Drager N. Trade and health: an agenda for action. Lancet 2009;373:768-73.
22. Baker P, Kay A, Walls H. Strengthening trade and health governance capacities to address non-communicable diseases in Asia: challenges and ways forward. Asia Pacific Policy Stud 2015;2:310-23.
23. Drahos P. Global governance of knowledge: patent offices and their clients. Cambridge University Press, 2010.
24. Freeman J, Keating G, Monasterio E, et al. Call for transparency in new generation trade deals. Lancet 2015;385:604-5.